Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant must be 18 years of age inclusive, at the time of signing the informed consent.
Participants with diagnosed sepsis according to sepsis-3 definition.
Participants with documented suspected origin of infection.
Informed consent of capable participant or, in case of participant being incapable of giving informed consent, consent for study inclusion will be sought according to applicable laws and regulations.
Patients who have received any investigational drug involving pharmacological interventions, or biological or cell therapy interventions or prohibited therapy within 28 days or five half-lives, whichever is longer, prior to screening/baseline.
Any reason that would make participation unadvisable, at the discretion of the investigator.
You may not be if
Patients deferred from other Intensive Care Units (ICUs).
Patients longer than 24 hours on ICU.
Known coagulation disorder.
Ongoing active clinically significant bleeding.
Participants experienced trauma or major surgery (within 4 weeks).
Active malignancy.
Decompensated liver impairment Child-Pugh Class C.
Moribund patients not expected to survive 24 hours (clinical decision).